Maintenance Notice (12:30 AM - 5:30 AM August 24, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.198
Maximum quantity allowed is 999
Merci de sélectionner la quantité
c-Jun N-Terminal Kinase (JNK) Inhibitor
No.175(October 2017)
SP600125 (1) is an inhibitor for JNK1, JNK2, and JNK3 with IC50 of 40 nM, 40 nM, and 90 nM respectively.1) Inhibitory constants of 1 for these JNKs are Ki = 0.19 μM. The inhibitory mechanism of 1 to the JNKs is ATP-competitive.
The selectivity of 1 was determined by crystal structural analysis using the ternary complex, JNK1-peptide fragment JIP1-1.2) JIP1 is a member of the JNK-interacting protein (JIP) family and contains a JNK binding domain (JBD), an SRC homology (SH3) domain, and a phosphotyrosine-binding (PTB) domain.3,4) JBD possesses the consensus sequence, R/KXXXXLXL.5) The sequence of peptide fragment JIP1 used in the research described above is RPKRPTTLNLF.2)
References
- 1)SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
- 2)Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125
- 3)A mammalian scaffold complex that selectively mediates MAP kinase activation
- 4)Scaffold proteins of MAP-kinase modules
- 5)Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.